跳至主要内容
临床试验/ISRCTN18430630
ISRCTN18430630
已完成
未知

Deep brain stimulation for severe obsessive compulsive disorder: efficacy and mechanisms of ventral striatum and subthalamic nucleus targets

niversity College London0 个研究点目标入组 6 人2015年4月22日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
niversity College London
入组人数
6
状态
已完成
最后更新
6年前

概览

简要总结

2019 results in https://www.ncbi.nlm.nih.gov/pubmed/30853111 (added 31/03/2020)

注册库
who.int
开始日期
2015年4月22日
结束日期
2015年8月31日
最后更新
6年前
研究类型
Interventional
性别
All

研究者

发起方
niversity College London

入排标准

入选标准

  • The inclusion criteria have been designed to be consistent with previous OCD DBS studies and to ensure that patients have not responded in a useful and sustained manner to either modifications of medication or any form of CBT
  • 1\. Patients must have undergone intensive treatment and have demonstrable treatment resistance as defined by:
  • 1\.1\. At least two SRIs for a minimum of 12 weeks at optimal British National Formulary (BNF) doses
  • 1\.2\.Augmentation of SRI treatment with antipsychotic drugs administered at maximally tolerated doses or by extending the SSRI dose beyond BNF limits
  • 1\.3\. Two trials of CBT of at least 10 hours
  • 1\.4\. Failed inpatient treatment
  • 2\. Patients must also satisfy the following criteria:
  • 2\.1\. Age \> 20 years
  • 2\.2\. Confirmation of a primary diagnosis of obsessive compulsive disorder (ICD10 F42\.0—F42\.9\)
  • 2\.3\. Duration of illness of at least 10 years

排除标准

  • 1\. Current diagnoses of substance misuse (ICD10 F10—F19\), organic brain syndrome (ICD10 F00—F09\), adult personality disorder (ICD10 F60—F69\), pervasive developmental disorder (ICD10 F84\); schizophrenia (ICD10 F20\-F29\) and bipolar disorder (ICD 10 F30\-31\)
  • 2\. Contraindications to neurosurgery
  • 3\. Pregnancy

结局指标

主要结局

未指定

相似试验